Co-administration of the mTORC1/TORC2 inhibitor INK128 and the Bcl-2/Bcl-xL antagonist ABT-737 kills human myeloid leukemia cells through Mcl-1 down-regulation and AKT inactivation.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mandy Mayo Aust Elisa Hawkins Catherine I Dumur Mohamed Rahmani Leonid B Reshko Rebecca E Parker Andrea Ferreira-Gonzalez |
| Publication date | October 9, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |